Sanofi inks 3 distribution pacts in India and Korea for CNS drugs and vaccines
Fierce Pharma
MARCH 27, 2024
For various reasons, pharma firms often favor distribution pacts rather than relying on local subsidiaries to market their drugs. |
Fierce Pharma
MARCH 27, 2024
For various reasons, pharma firms often favor distribution pacts rather than relying on local subsidiaries to market their drugs. |
Fierce Pharma
AUGUST 18, 2023
Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Novartis’ Sandoz spinoff is right around the corner, and to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
APRIL 2, 2024
How will specialty distribution keep up? Joining us on this episode of The Top Line is Jeff Beck, Chief Development Officer at BioCare. | The patient journey is evolving.
Pharmaceutical Commerce
AUGUST 11, 2022
Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.
Advertisement
Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support studies throughout (..)
MedCity News
AUGUST 7, 2024
Cigna is distributing about $3 million to 22 nonprofits addressing youth mental health. The post Cigna Distributes Grants to 22 Nonprofits Focused on Youth Mental Health appeared first on MedCity News. Over the next three years, the company is allocating $9 million total.
Fierce Pharma
OCTOBER 4, 2023
government is winding down its distribution of COVID-19 countermeasures. | The government will wind down its Lagevrio distribution ahead of the transition, the Administration for Strategic Preparedness and Response said. As long expected, the U.S.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.
Advertisement
A dedicated Case Manager provides end-to-end supply chain management and 24/7 oversight and support to help ensure the seamless manufacturing and distribution of each therapy dose to every patient.
Advertisement
Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content